Genome-Based Therapeutics: Targeted Drug Discovery and Development
Publisher: National Academies Press 2012
Number of pages: 89
Objectives: To examine the impact of and investment in genetic and genomic technologies and data in drug discovery and development; To examine and discuss the challenges for incorporating genomic technologies into drug development and to explore solutions to remedy those challenges; To discuss and explore how innovative, novel, and global partnerships between academia, industry, foundations, and government can enable the use of genomic information for more efficient and effective drug discovery and development programs.
Home page url
Download or read it online for free here:
- International Agency for Research on Cancer
This volume provides an assessment of the carcinogenicity of 14 drugs and herbal products. The authors relied on epidemiological studies to evaluate the carcinogenic hazard to humans exposed to the drugs digoxin, pioglitazone and hydrochlorothiazide.
by C. Robin Timmons, Leonard W. Hamilton - Rutgers University
From the table of contents: Behavior and the Chemistry of The Brain; General Methods of Brain/Behavior Analysis; Psychopharmacological Concepts; Specific Fears, Vague Anxieties And The Autonomic Nervous System; Pain and Other Stressors; etc.
by Cecilia Maldonado - InTech
This book comprises many aspects of pain treatment and the drugs involved in it. From old analgesics for pain alleviation to analgesics potential for diminishing oxidative stress; from pharmacological therapies to electrical ones ...
by J. Eric McDuffie (ed.) - InTech
Because the incidence of neurobehavioral hazards and risks of exogenous compounds remain subject matter of interest, predictive tools have evolved, including novel translational in vitro models, biomarkers, newer epidemiological research tools, etc.